Thrombotic events and prophylactic anticoagulation in pediatric patients with COVID-19: a systematic review and meta-analysis

References

• Hematology ASo. COVID-19 and coagulopathy: frequently asked questions 2020. Available from: https://www.hematology.org/covid-19/covid-19-and-coagulopathy.
   Google Scholar
• Song JC, Wang G, Zhang W, et al. Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19. Mil Med Res. 2020;7(1):19. [published Online First: 20200420]. doi:10.1186/s40779-020-00247-7
   PubMed Web of Science ®Google Scholar
• Cao Q, Chen YC, Chen CL, et al. SARS-CoV-2 infection in children: transmission dynamics and clinical characteristics. J Formos Med Assoc. 2020;119(3):670–673. [published Online First: 20200302]. doi:10.1016/j.jfma.2020.02.009
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu F, Wang C, et al. Children hospitalized With severe COVID-19 in Wuhan. Pediatr Infect Dis J. 2020;39(7):e91–e94. doi:10.1097/inf.0000000000002739
   PubMed Web of Science ®Google Scholar
• Giannis D, Barish MA, Goldin M, et al. Incidence of venous thromboembolism and mortality in patients with initial presentation of COVID-19. J Thromb Thrombolysis. 2021;51(4):897–901. [published Online First: 20210305]. doi:10.1007/s11239-021-02413-7
   PubMed Web of Science ®Google Scholar
• Karimi M, Bozorgi H, Zarei T, et al. Antithrombotic prophylaxis in children and adolescents’ patients with SARS-CoV-2 (COVID-19) infection: a practical guidance for clinicians. Acta Biomed. 2020;91(4):e2020170. [published Online First: 20201110]. doi:10.23750/abm.v91i4.10720
   PubMedGoogle Scholar
• Goldenberg NA, Sochet A, Albisetti M, et al. Consensus-based clinical recommendations and research priorities for anticoagulant thromboprophylaxis in children hospitalized for COVID-19-related illness. J Thromb Haemost. 2020;18(11):3099–3105. doi:10.1111/jth.15073
   PubMed Web of Science ®Google Scholar
• Yan A, Parsons C, Caplan G, et al. Improving guideline-concordant thromboprophylaxis prescribing for children admitted to hospital with COVID-19. Pediatr Blood Cancer. 2023;70(2):e30112. [published Online First: 20221210]. doi:10.1002/pbc.30112
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10(1):89. [published Online First: 20210329]. doi:10.1186/s13643-021-01626-4
   PubMed Web of Science ®Google Scholar
• Research NIfH. International prospective register of systematic reviews (PROSPERO). Available from: https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=414338.
   Google Scholar
• Mitchell LG, Goldenberg NA, Male C, et al. Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thromboembolism and pulmonary embolism in children. J Thromb Haemost. 2011;9(9):1856–1858. doi:10.1111/j.1538-7836.2011.04433.x
   PubMed Web of Science ®Google Scholar
• Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Br Med J. 2016;355:i4919. [published Online First: 20161012]. doi:10.1136/bmj.i4919.
   PubMed Web of Science ®Google Scholar
• The R Foundation for Statistical Computing Version 4.2.3. [program], 2023.
   Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558. doi:10.1002/sim.1186
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. Br Med J. 2003;327(7414):557–560. doi:10.1136/bmj.327.7414.557.
   PubMed Web of Science ®Google Scholar
• Sochet AA, Morrison JM, Jaffray J, et al. Enoxaparin thromboprophylaxis in children hospitalized for COVID-19: A phase 2 trial. Pediatrics. 2022;150(1). doi:10.1542/peds.2022-056726
   PubMed Web of Science ®Google Scholar
• Mitchell WB, Davila J, Keenan J, et al. Children and young adults hospitalized for severe COVID-19 exhibit thrombotic coagulopathy. Pediatr Blood Cancer. 2021;68(7):e28975. [published Online First: 20210304]. doi:10.1002/pbc.28975
   PubMed Web of Science ®Google Scholar
• Hodes AD, Villasana-Gomez G, Traube L, et al. A comparison of pulmonary embolism in pediatric and adult patients with acute COVID-19. Clin Imaging. 2022;85:10–13. doi:10.1016/j.clinimag.2022.02.015
   PubMed Web of Science ®Google Scholar
• Chima M, Williams D, Thomas NJ, et al. COVID-19-Associated pulmonary embolism in pediatric patients. Hosp Pediatr. 2021;11(6):e90–e94. [published Online First: 20210330]. doi:10.1542/hpeds.2021-005866
   PubMedGoogle Scholar
• Antoon JW, Grijalva CG, Thurm C, et al. Factors associated With COVID-19 disease severity in US children and adolescents. J Hosp Med. 2021;16(10):603–610. doi:10.12788/jhm.3689
   PubMed Web of Science ®Google Scholar
• Aguilera-Alonso D, Murias S, Martínez-de-Azagra Garde A, et al. Prevalence of thrombotic complications in children with SARS-CoV-2. Arch Dis Child. 2021;106(11):1129–1132. [published Online First: 20210430]. doi:10.1136/archdischild-2020-321351
   PubMed Web of Science ®Google Scholar
• Whitworth H, Sartain SE, Kumar R, et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood. 2021;138(2):190–198. doi:10.1182/blood.2020010218
   PubMed Web of Science ®Google Scholar
• Saleh NY, Aboelghar HM, Salem SS, et al. The severity and atypical presentations of COVID-19 infection in pediatrics. BMC Pediatr. 2021;21(1):144. [published Online First: 20210325]. doi:10.1186/s12887-021-02614-2
   PubMed Web of Science ®Google Scholar
• Schmitz AH, Wood KE, Burghardt EL, et al. Thromboprophylaxis for children hospitalized with COVID-19 and MIS-C. Res Pract Thromb Haemost. 2022;6(5):e12780. [published Online First: 20220807]. doi:10.1002/rth2.12780
   PubMed Web of Science ®Google Scholar
• Karimi M, Sanaei Dashti A, Haghpanah S, et al. Thromboprophylaxis outcome in childhood SARS-CoV-2 infection: A single-center experience. J Pediatr Hematol Oncol. 2023;45(1):e97–e102. [published Online First: 20220927]. doi:10.1097/mph.0000000000002557
   PubMed Web of Science ®Google Scholar
• Tehseen S, Williams S, Robinson J, et al. Thrombosis and hemorrhage experienced by hospitalized children with SARS-CoV-2 infection or MIS-C: results of the PICNIC registry. Pediatric Blood Cancer. 2022;69(9):e29793.
   PubMed Web of Science ®Google Scholar
• Noni M, Koukou DM, Tritzali M, et al. Coagulation abnormalities and management in hospitalized pediatric patients With COVID-19. Pediatr Infect Dis J. 2022;41(7):570–574. [published Online First: 20220607]. doi:10.1097/inf.0000000000003545.
   PubMed Web of Science ®Google Scholar
• Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev. 1987;9:1–30. doi:10.1093/oxfordjournals.epirev.a036298
   PubMed Web of Science ®Google Scholar
• Razavi A, Davoodi L, Shojaei L, et al. COVID-19 in children: a narrative review. Open Access Maced J Med Sci. 2020;8(T1):23–31. doi:10.3889/oamjms.2020.4714
   Google Scholar
• Levi M, Thachil J, Iba T, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–ee40. [published Online First: 20200511]. doi:10.1016/s2352-3026(20)30145-9
   PubMed Web of Science ®Google Scholar
• Llitjos JF, Leclerc M, Chochois C, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743–1746. [published Online First: 20200527]. doi:10.1111/jth.14869
   PubMed Web of Science ®Google Scholar